{"id":"https://openalex.org/W4414156232","doi":"https://doi.org/10.61919/4892av69","title":"Possible Targets for the Treatment of Alzheimer\u2019s Disease \u2013 A Narrative Review","display_name":"Possible Targets for the Treatment of Alzheimer\u2019s Disease \u2013 A Narrative Review","publication_year":2025,"publication_date":"2025-09-09","ids":{"openalex":"https://openalex.org/W4414156232","doi":"https://doi.org/10.61919/4892av69"},"language":"en","primary_location":{"id":"doi:10.61919/4892av69","doi":"https://doi.org/10.61919/4892av69","is_oa":true,"landing_page_url":"https://doi.org/10.61919/4892av69","pdf_url":"https://jhwcr.com/index.php/jhwcr/article/download/669/642","source":{"id":"https://openalex.org/S5407043305","display_name":"Journal of Health Wellness and Community Research","issn_l":"3007-0570","issn":["3007-0570"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Health, Wellness and Community Research","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://jhwcr.com/index.php/jhwcr/article/download/669/642","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102695546","display_name":"Aminah Khalid","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aminah Khalid","raw_affiliation_strings":["Lahore Grammar School, Lahore, Pakistan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lahore Grammar School, Lahore, Pakistan","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5104336529","display_name":"Zainab Yousaf","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2987782246","display_name":"Farooq Hospital","ror":"https://ror.org/04e3aws14","country_code":"PK","type":"healthcare","lineage":["https://openalex.org/I2987782246"]}],"countries":["PK"],"is_corresponding":false,"raw_author_name":"Zainab Yousaf","raw_affiliation_strings":["Farooq Hospital Westwood, Lahore, Pakistan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Farooq Hospital Westwood, Lahore, Pakistan","institution_ids":["https://openalex.org/I2987782246"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.09066488,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"e669","last_page":"e669"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.014700000174343586,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9900000095367432},{"id":"https://openalex.org/keywords/disease-modifying-therapy","display_name":"disease-modifying therapy","score":0.8029999732971191},{"id":"https://openalex.org/keywords/acetylcholinesterase-inhibitors","display_name":"acetylcholinesterase inhibitors","score":0.8759999871253967},{"id":"https://openalex.org/keywords/memantine","display_name":"memantine","score":0.968999981880188},{"id":"https://openalex.org/keywords/aducanumab","display_name":"aducanumab","score":0.8820000290870667},{"id":"https://openalex.org/keywords/lecanemab","display_name":"lecanemab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/donanemab","display_name":"donanemab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/anti-amyloid-therapy","display_name":"anti-amyloid therapy","score":0.656000018119812},{"id":"https://openalex.org/keywords/tau-targeted-therapy","display_name":"tau-targeted therapy","score":0.7919999957084656},{"id":"https://openalex.org/keywords/tau-immunotherapy","display_name":"tau immunotherapy","score":0.6330000162124634},{"id":"https://openalex.org/keywords/amyloid-related-imaging-abnormalities","display_name":"amyloid-related imaging abnormalities","score":0.8299999833106995},{"id":"https://openalex.org/keywords/blood-brain-barrier","display_name":"blood-brain barrier","score":0.5899999737739563},{"id":"https://openalex.org/keywords/exosomes","display_name":"exosomes","score":0.6800000071525574},{"id":"https://openalex.org/keywords/nanoparticles","display_name":"nanoparticles","score":0.5509999990463257},{"id":"https://openalex.org/keywords/intranasal-insulin","display_name":"intranasal insulin","score":0.7160000205039978},{"id":"https://openalex.org/keywords/masitinib","display_name":"masitinib","score":0.9279999732971191},{"id":"https://openalex.org/keywords/anti-inflammatory-therapy","display_name":"anti-inflammatory therapy","score":0.5559999942779541}],"concepts":[{"id":"https://openalex.org/C2779484449","wikidata":"https://www.wikidata.org/wiki/Q412189","display_name":"Memantine","level":4,"score":0.7265999913215637},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6751000285148621},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6660000085830688},{"id":"https://openalex.org/C2984863031","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Cognitive decline","level":4,"score":0.6353999972343445},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.6098999977111816},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5964000225067139},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5048999786376953},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4758000075817108},{"id":"https://openalex.org/C169900460","wikidata":"https://www.wikidata.org/wiki/Q2200417","display_name":"Cognition","level":2,"score":0.4690999984741211},{"id":"https://openalex.org/C2776332859","wikidata":"https://www.wikidata.org/wiki/Q411887","display_name":"Rivastigmine","level":5,"score":0.45419999957084656},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3921000063419342},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.3885999917984009},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.35850000381469727},{"id":"https://openalex.org/C3020000205","wikidata":"https://www.wikidata.org/wiki/Q2412849","display_name":"Narrative review","level":2,"score":0.3467999994754791},{"id":"https://openalex.org/C189708586","wikidata":"https://www.wikidata.org/wiki/Q1504425","display_name":"Systematic review","level":3,"score":0.323199987411499},{"id":"https://openalex.org/C2780904820","wikidata":"https://www.wikidata.org/wiki/Q415081","display_name":"Donepezil","level":4,"score":0.3188000023365021},{"id":"https://openalex.org/C14216870","wikidata":"https://www.wikidata.org/wiki/Q3872","display_name":"Neuropsychology","level":3,"score":0.3059000074863434},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.2842000126838684},{"id":"https://openalex.org/C70410870","wikidata":"https://www.wikidata.org/wiki/Q199906","display_name":"Clinical psychology","level":1,"score":0.27320000529289246},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.2646999955177307},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.2614000141620636},{"id":"https://openalex.org/C2781092381","wikidata":"https://www.wikidata.org/wiki/Q5874546","display_name":"Hoarding (animal behavior)","level":3,"score":0.25220000743865967}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.61919/4892av69","doi":"https://doi.org/10.61919/4892av69","is_oa":true,"landing_page_url":"https://doi.org/10.61919/4892av69","pdf_url":"https://jhwcr.com/index.php/jhwcr/article/download/669/642","source":{"id":"https://openalex.org/S5407043305","display_name":"Journal of Health Wellness and Community Research","issn_l":"3007-0570","issn":["3007-0570"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Health, Wellness and Community Research","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.61919/4892av69","doi":"https://doi.org/10.61919/4892av69","is_oa":true,"landing_page_url":"https://doi.org/10.61919/4892av69","pdf_url":"https://jhwcr.com/index.php/jhwcr/article/download/669/642","source":{"id":"https://openalex.org/S5407043305","display_name":"Journal of Health Wellness and Community Research","issn_l":"3007-0570","issn":["3007-0570"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Health, Wellness and Community Research","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4414156232.pdf","grobid_xml":"https://content.openalex.org/works/W4414156232.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4391375266","https://openalex.org/W2748952813","https://openalex.org/W2348886128","https://openalex.org/W2388067091","https://openalex.org/W2367656648","https://openalex.org/W2350200549","https://openalex.org/W2362132076","https://openalex.org/W2965396777","https://openalex.org/W2389168924","https://openalex.org/W2067294484"],"abstract_inverted_index":{"Background:":[0],"Alzheimer\u2019s":[1],"disease":[2],"(AD)":[3],"accounts":[4],"for":[5,50],"60\u201370%":[6],"of":[7,96,207,283,329],"dementia":[8],"cases":[9],"worldwide,":[10],"with":[11,129,295],"over":[12,179],"55":[13],"million":[14],"people":[15],"currently":[16],"affected":[17],"and":[18,32,47,57,66,73,87,102,105,114,148,161,182,196,220,242,257,285,297,306,327],"numbers":[19],"projected":[20],"to":[21,37,80,156,229],"triple":[22],"by":[23,123,146,174,194],"2050.":[24],"Despite":[25],"extensive":[26],"research,":[27],"most":[28],"therapies":[29,49,274],"remain":[30,254,275],"symptomatic,":[31],"the":[33,115,177],"global":[34],"burden":[35],"continues":[36],"rise.":[38],"Objective:":[39],"To":[40],"narratively":[41,106],"synthesize":[42],"recent":[43],"evidence":[44],"on":[45,94,126,176,317],"approved":[46],"investigational":[48],"AD,":[51],"emphasizing":[52],"mechanisms,":[53],"efficacy":[54],"signals,":[55],"safety,":[56],"clinical":[58,98,159],"implementation":[59,298],"challenges.":[60,299],"Methods:":[61],"Literature":[62],"from":[63],"PubMed/MEDLINE,":[64],"ClinicalTrials.gov,":[65],"FDA/EMA":[67],"regulatory":[68,85],"documents":[69],"published":[70],"between":[71],"2019":[72],"2025":[74],"was":[75,78,162],"reviewed.":[76],"Priority":[77],"given":[79],"pivotal":[81,289],"randomized":[82],"controlled":[83],"trials,":[84],"labels,":[86],"high-quality":[88],"systematic":[89],"reviews.":[90],"Data":[91],"were":[92],"extracted":[93],"mechanisms":[95],"action,":[97],"outcomes,":[99],"adverse":[100],"effects,":[101],"monitoring":[103],"requirements,":[104],"synthesized.":[107],"Results:":[108],"Acetylcholinesterase":[109],"inhibitors":[110],"(donepezil,":[111],"rivastigmine,":[112],"galantamine)":[113],"NMDA":[116],"antagonist":[117],"memantine":[118],"consistently":[119],"improve":[120,260],"cognitive":[121,172,231],"scores":[122],"1\u20133":[124],"points":[125],"standard":[127],"scales,":[128],"benefits":[130],"lasting":[131],"6\u201312":[132],"months":[133,181],"before":[134],"decline":[135,173,193],"resumes.":[136],"Combination":[137],"therapy":[138],"yields":[139],"marginally":[140],"greater":[141],"effects":[142],"but":[143,154,226,253,277,311],"is":[144,270],"limited":[145],"tolerability":[147],"cost.":[149],"Aducanumab":[150],"demonstrated":[151],"amyloid":[152],"reduction":[153],"failed":[155],"show":[157,222],"consistent":[158],"benefit":[160],"discontinued":[163],"in":[164,186,199,250,264,279],"2024.":[165],"In":[166],"contrast,":[167],"lecanemab":[168,284],"(CLARITY-AD,":[169],"n\u22481800)":[170],"slowed":[171],"~27%":[175],"CDR-SB":[178],"18":[180],"achieved":[183],"FDA":[184],"approval":[185,198],"2023,":[187],"while":[188],"donanemab":[189,286],"(TRAILBLAZER-ALZ-2,":[190],"n\u22481700)":[191],"reduced":[192],"~35%":[195],"gained":[197],"2024,":[200],"though":[201,267],"both":[202],"carry":[203],"a":[204,288],"20\u201330%":[205],"risk":[206],"amyloid-related":[208],"imaging":[209],"abnormalities":[210],"(ARIA)":[211],"requiring":[212],"MRI":[213],"monitoring.":[214],"Tau":[215],"immunotherapies":[216],"such":[217],"as":[218],"AADvac-1":[219],"bepranemab":[221],"robust":[223],"target":[224],"engagement":[225],"have":[227],"yet":[228],"demonstrate":[230],"efficacy.":[232],"Adjunctive":[233],"approaches,":[234],"including":[235],"masitinib":[236],"(tyrosine":[237],"kinase":[238],"inhibition),":[239],"intranasal":[240],"insulin,":[241],"albumin/plasma":[243],"exchange":[244],"(AMBAR":[245],"study),":[246],"report":[247],"modest":[248,278],"signals":[249],"exploratory":[251],"endpoints":[252],"unconfirmed.":[255],"Nanoparticle":[256],"exosome-based":[258],"platforms":[259],"blood\u2013brain":[261],"barrier":[262],"penetration":[263],"preclinical":[265],"models,":[266],"human":[268],"translation":[269],"limited.":[271],"Conclusion:":[272],"Symptomatic":[273],"relevant":[276],"impact.":[280],"The":[281],"approvals":[282],"mark":[287],"shift":[290],"toward":[291],"disease-modifying":[292],"treatment,":[293],"albeit":[294],"safety":[296],"Tau-directed":[300],"strategies,":[301],"anti-inflammatory":[302],"agents,":[303],"metabolic":[304],"modulators,":[305],"regenerative":[307],"approaches":[308],"are":[309],"promising":[310],"unproven.":[312],"Future":[313],"progress":[314],"will":[315],"depend":[316],"integrating":[318],"biomarker-driven":[319],"diagnosis,":[320],"rigorous":[321],"ARIA":[322],"management,":[323],"equitable":[324],"health-system":[325],"planning,":[326],"development":[328],"multimodal":[330],"therapeutic":[331],"combinations.":[332]},"counts_by_year":[],"updated_date":"2026-08-23T07:36:19.812096","created_date":"2025-10-10T00:00:00"}